Page last updated: 2024-12-08
furprofen
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
furprofen: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 162201 |
| SCHEMBL ID | 5080262 |
| MeSH ID | M0156510 |
Synonyms (20)
| Synonym |
|---|
| 4-(2-furanylcarbonyl)-alpha-methylbenzeneacetic acid |
| benzeneacetic acid, 4-(2-furanylcarbonyl)-alpha-methyl- |
| furprofen |
| 66318-17-0 |
| 2-[4-(furan-2-carbonyl)phenyl]propanoic acid |
| wn6tvw60gv , |
| unii-wn6tvw60gv |
| 2-(4-(2-furoyl)phenyl)propionic acid |
| benzeneacetic acid, 4-(2-furanylcarbonyl)-.alpha.-methyl- |
| furprofen [mart.] |
| 4-(2-furanylcarbonyl)-.alpha.-methylbenzeneacetic acid |
| furprofen [who-dd] |
| SCHEMBL5080262 |
| 2-[4-(2'-furoyl)phenyl]propionic acid |
| HY-106907 |
| DTXSID20984893 |
| Q27292733 |
| CS-0026888 |
| MS-23453 |
| AKOS040733209 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (3)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.82
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.82) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||